RBC Downgrades FactSet Research Systems to Sector Perform From Outperform, Expects 'Revenue Slowdown and Potentially Higher Tax Rate' to Weigh Down Earnings Growth, Slashes Price Target to $464 From $500
RBC Cuts Price Target on Tremor International to $8 From $11 Amid Q2 Revenue Miss, Peer Multiple Contraction; Outperform Kept
B. Riley Cuts OptimizeRx's Price Target to $18 From $28 on Muted H2 Revenue Expectation, Keeps Buy Rating
No Data
No Data